Jiang Liu

Title: Jiang Liu - Innovator in Uremic Cardiomyopathy Treatment

Introduction

Jiang Liu is a notable inventor based in Huntington, WV (US). He has made significant contributions to the field of medical treatments, particularly focusing on uremic cardiomyopathy. His innovative approaches aim to improve the quality of life for patients suffering from this condition.

Latest Patents

Jiang Liu holds a patent for "Compositions and methods for treatment of uremic cardiomyopathy." This patent outlines methods for treating uremic cardiomyopathy, which include administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to a subject in need. Additionally, the polypeptide antagonist can include a cell-penetrating polypeptide. The patent also covers methods for treating anemia, including anemia associated with chronic kidney disease.

Career Highlights

Jiang Liu is affiliated with the Marshall University Research Corporation, where he conducts research and develops innovative solutions for medical challenges. His work has garnered attention for its potential impact on treating complex health issues.

Collaborations

Jiang Liu collaborates with esteemed colleagues, including Zijian Xie and Joseph I Shapiro, to advance research and development in his field. Their combined expertise contributes to the innovative solutions being explored at the research corporation.

Conclusion

Jiang Liu's contributions to the treatment of uremic cardiomyopathy and related conditions highlight his role as a significant inventor in the medical field. His innovative methods and collaborations pave the way for advancements in patient care and treatment options.